Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Labriola, Matthew K., and Daniel J. George. “Setting a new standard for long-term survival in metastatic kidney cancer.” Cancer 128, no. 11 (June 1, 2022): 2058–60. https://doi.org/10.1002/cncr.34177.
Zhou, Katherine, Chenyu Lin, Michelle Green, Bennett Caughey, Michael Datto, John Strickler, and Matthew McKinney. “Frequency of Practice-Changing Findings Identified by Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies.” In American Society of Clinical Oncology, 2022.
Palencia-Madrid, Leire, Miriam Baeta, Tamara Kleinbielen, Nerea Toro-Delgado, Patricia Villaescusa, Elena Sanchez-Bustamante, Marian M. de Pancorbo, et al. “Post-Austronesian migrational wave of West Polynesians to Micronesia.” Gene 823 (May 20, 2022): 146357. https://doi.org/10.1016/j.gene.2022.146357.
Armstrong, Andrew J., Arun A. Azad, Taro Iguchi, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, et al. “Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer.” J Clin Oncol 40, no. 15 (May 20, 2022): 1616–22. https://doi.org/10.1200/JCO.22.00193.
Wei, Shiyou, Delong Yin, Shengnan Yu, Xiang Lin, Milan R. Savani, Kuang Du, Yin Ku, et al. “Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas.” Clin Cancer Res 28, no. 10 (May 13, 2022): 2180–95. https://doi.org/10.1158/1078-0432.CCR-21-0833.
Low, Justin T., Vidyalakshmi Chandramohan, Michelle L. Bowie, Michael C. Brown, Matthew S. Waitkus, Aaron Briley, Kevin Stevenson, et al. “Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition.” Cancer Cell 40, no. 5 (May 9, 2022): 439–40. https://doi.org/10.1016/j.ccell.2022.04.009.
In, Haejin, Srawani Sarkar, Jessica Ward, Patricia Friedmann, Michael Parides, Julie Yang, and Meira Epplein. “Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study using the PLCO Cancer Screening Trial Data.” Cancer Epidemiol Biomarkers Prev, May 9, 2022. https://doi.org/10.1158/1055-9965.EPI-21-1328.
Chen, Allan S., Hongliang Liu, Yufeng Wu, Sheng Luo, Edward F. Patz, Carolyn Glass, Li Su, Mulong Du, David C. Christiani, and Qingyi Wei. “Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.” Mol Carcinog, May 3, 2022. https://doi.org/10.1002/mc.23400.
Scherpereel, Arnaud, Scott Antonia, Yolanda Bautista, Francesco Grossi, Dariusz Kowalski, Gérard Zalcman, Anna K. Nowak, et al. “First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.” Lung Cancer 167 (May 2022): 8–16. https://doi.org/10.1016/j.lungcan.2022.03.012.
Kolmar, Amanda, Arif H. Kamal, and Karen E. Steinhauser. “Clinician End-of-Life Experiences With Pediatric Muslim Patients at a US Quaternary Care Center.” J Pain Symptom Manage 63, no. 5 (May 2022): 673–79. https://doi.org/10.1016/j.jpainsymman.2022.01.005.